DalsnaFinance › IPOs › Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. completed its initial public offering on NASDAQ on January 31, 2020, pricing at $17.00 a share.
| Ticker | ARQT |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | January 31, 2020 |
| Offering price | $17.00 |
| Shares offered | 9,375,000 |
| Total raised | $159M |
Arcutis Biotherapeutics, Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.